Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

A Blood Test That Detects Alzheimer's Disease Years Before Brain Scans Can Just Took a Major Leap Forward — Harvard Study Confirms It Outperforms PET Imaging in Early Detection

Harvard Mass General Brigham study in Nature Communications (April 2026): plasma pTau217 blood test detects Alzheimer's progression years before PET scans. FDA already cleared Lumipulse pTau217 test for symptomatic patients.

Medical Daily

The Antibiotic Last Line of Defense Against Gonorrhea Just Lost More Ground: WHO Data Shows Sixfold Resistance Rise and U.S. Is Running Out of Options

WHO EGASP data show ceftriaxone resistance in gonorrhea rose more than sixfold globally from 2022 to 2024. Ceftriaxone is the only U.S.-recommended gonorrhea treatment. New pipeline drugs show promise but are not yet approved.

Medical Daily

US drug regulator issues import alert for drugs made at a Dabur India plant

The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed significant issues with data integrity and factory maintenance. Critical manufacturing records were reportedly falsified. Live birds and droppings were also found in a raw material warehouse.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA issues new kidney warning for weight loss pill

Alli was the first over-the-counter weight loss pill approved by the U.S. Food and Drug Administration

The Independent UK

FDA's e-cigarette authorization: Fruity vapes not significantly better than tobacco ones

A new memo from U.S. health regulators is raising questions about a recent decision to authorize the first fruit-flavored e-cigarettes for adult smokers

AAP

FDA memo reveals fruit-flavored e-cigarettes aren’t better for quitting smoking

The six-page FDA memo suggests regulators sidestepped previous concerns about the risks associated with sweet vaping flavors

The Independent UK

A 1,000-Year-Old Chinese Herb Just Passed Modern Scientific Scrutiny for Hair Loss

A 2026 review in the Journal of Holistic Integrative Pharmacy confirms Polygonum multiflorum (He Shou Wu) combats hair loss through four simultaneous biological mechanisms: DHT blocking, follicle regeneration signaling, anti-apoptosis, and improved scalp circulation.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

AI Is Now Detecting Cancer Years Before Doctors Can — New 2026 Research Shows How Machine Learning Is Transforming Diagnosis

A 2026 Nature Cancer AI identified 18 cancer types with high accuracy from minimal slides. A Mayo Clinic AI detected pancreatic cancer up to 3 years before diagnosis — nearly doubling specialist rates.

Medical Daily

Alzheimer's Treatment Is Entering a New Era — Here Is Everything That Has Changed in 2026

Leqembi and Kisunla are slowing Alzheimer's decline by 27-35% in early-stage patients. The 2026 drug pipeline has 158 candidates in 192 trials. Prevention trials are beginning. Here's the full update.

Medical Daily

The FDA Finally Approved a New Sunscreen Ingredient. It Only Took Over 25 Years.

The FDA's burdensome regulatory process has throttled sunscreen innovation.

Reason

Finerenone Kidney Drug Shown to Protect Heart and Kidneys in Millions More Patients After Three Major 2026 Studies

Three major studies published in NEJM, JAMA, and The Lancet in June 2026 show finerenone protects kidneys and hearts in non-diabetic CKD patients, expanding its potential reach to millions.

Medical Daily

Pet food recall expands to 20 US states amid concerns over serious neurological symptoms

Product could have potentially low levels of Vitamin B1, which is essential for ‘neurologic function in both cats and dogs’

The Independent UK

Medicare Is About to Cover Weight-Loss Drugs for the First Time — Here's What the GLP-1 Bridge Program Means for Millions of Americans with Obesity

Medicare's GLP-1 Bridge launches July 1, 2026, offering eligible Part D enrollees Wegovy and Zepbound for $50/month — the first-ever Medicare coverage for obesity-specific GLP-1 drugs.

Medical Daily

FDA Approves Bemotrizinol: First New Sunscreen Ingredient in 25 Years to Hit U.S. Market in 2026

The FDA approved bemotrizinol on June 9, 2026 — the first new sunscreen ingredient in the U.S. in more than 25 years. It provides superior UVA protection already used worldwide.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Two Breakthrough Treatments Are Changing the Outlook for Americans with Treatment-Resistant Depression

New 2026 clinical data on Caplyta and Spravato offer major new hope for the roughly 7 million Americans with treatment-resistant depression. Here's what the evidence now shows.

Medical Daily

Salmonella Outbreak Linked to Moringa Supplements Expands to 119 Cases Across 36 States — FDA Issues New Recall

The FDA has expanded a Salmonella recall linked to moringa dietary supplements. 119 people across 36 states have been sickened, with 32 hospitalizations.

Medical Daily

Listeria Outbreak Kills One, Hospitalizes Seven: Soft Ricotta and Requeson Cheese Recalled in New York, Virginia, Maryland

A Listeria outbreak linked to Clover Hill Dairy soft ricotta and requesón cheese has killed one person and hospitalized seven others across three states.

The Independent UK

Cheese recalled in US after being linked to listeria outbreak that has left one dead and multiple sick

The cheese was sold in three different states

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

What is bemotrizinol? The sunscreen ingredient that was just approved by FDA

IN FULL

The Independent UK

New sunscreen ingredient approved in US for first time in 25 years

Bemotrizinol received authorization from European authorities in 1999 and was first submitted to the FDA for review as far back as 2005

MarketBeat

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase

Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol

The Independent UK

FDA OKs first new sunscreen ingredient in more than 25 years

Federal health regulators have signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years

Marie Claire

The FDA Just Approved a New Sunscreen Filter, Bemotrizinol, the First In 27 Years

Your skin is rejoicing.

Medical Daily

FDA Warns New Yorkers: Hepatitis A Linked to Frozen Blood Clams Sold in New York State — Illnesses Span Months

The FDA issued a public alert about hepatitis A-linked blood clams distributed in New York. Cases traced to La Serranita frozen blood clams imported from Ecuador. First illness reported in July 2025.

Medical Daily

FDA Issues Listeria Warning for Soft Ricotta and Requeson Cheese Sold in Philadelphia and Northeast Markets — Do Not Eat Recalled Products

The FDA issued a Listeria outbreak advisory on June 4, 2026, linked to requeson/soft ricotta cheese by Clover Hill Dairy. Products distributed in the Northeast, including Philadelphia-area markets.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

347 stories

Mayo

318 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.